Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: Menatetrenone [INN:JAN]
RN: 863-61-6
UNII: 27Y876D139
InChIKey: DKHGMERMDICWDU-GHDNBGIDSA-N

Classification Codes

  • Coagulants
  • Drug / Therapeutic Agent
  • Hematologic Agents
  • Hemostatics
  • Reproductive Effect

Molecular Formula

  • C31-H40-O2

Molecular Weight

  • 444.655
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Menaquinone 4
  • Menatetrenone
  • Menatetrenone [INN:JAN]

Synonyms

  • 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-1,4-naphthochinon
  • 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-1,4-naphthoquinone
  • 2-Methyl-3-geranylgeranyl-1,4-naphthoquinone
  • 2-Methyl-3-trans-tetraprenyl-1,4-naphthoquinone
  • E3100
  • K2(sub 20)
  • Kaytwo
  • Kephton
  • Menaquinone K4
  • Menaquinone-4
  • Menatetrenona
  • Menatetrenona [INN-Spanish]
  • Menatetrenone
  • Menatetrenonum
  • Menatetrenonum [INN-Latin]
  • MK4
  • UNII-27Y876D139
  • Vitamin K2(sub 20)
  • Vitamin MK 4

Systematic Names

  • 1,4-Naphthalenedione, 2-methyl-3-((2E,6E,10E)3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-
  • 1,4-Naphthalenedione, 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-, (E,E,E)-

Superlist Name

  • Menaquinone-4

Registry Numbers

CAS Registry Number

  • 863-61-6

FDA UNII

  • 27Y876D139

Other Registry Numbers

  • 15261-37-7
  • 20977-31-5
  • 39776-41-5

System Generated Number

  • 0000863616

Structure Descriptors

InChI

InChI=1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+

InChIKey

DKHGMERMDICWDU-GHDNBGIDSA-N

Smiles

CC(=CCC\C(=C\CC\C(=C\CC\C(=C\CC1=C(C)C(=O)c2ccccc2C1=O)\C)\C)\C)C

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD oral > 1gm/kg (1000mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
dog LD unreported > 3gm/kg (3000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 37, Pg. 2518, 1995.
dog LD50 intravenous > 40mL/kg (40mL/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BLOOD: PIGMENTED OR NUCLEATED RED BLLOD CELLS
Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 2003, 1991.
monkey LD50 intravenous > 10mL/kg (10mL/kg) BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED) Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 2003, 1991.
mouse LD oral > 5mg/kg (5mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
mouse LD50 intravenous > 40mL/kg (40mL/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 2003, 1991.
mouse LDLo intraperitoneal 5gm/kg (5000mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
mouse LDLo subcutaneous 5gm/kg (5000mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
rabbit LD intravenous > 100mg/kg (100mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 461, 1971.
rabbit LDLo subcutaneous 100mg/kg (100mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 461, 1971.
rat LD oral > 5gm/kg (5000mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
rat LD subcutaneous > 5gm/kg (5000mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
rat LD50 intravenous > 40mL/kg (40mL/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 2003, 1991.
rat LDLo intraperitoneal 5gm/kg (5000mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.